Skip to Main Content

Good morning, everyone, and welcome to the middle of the week. Congratulations on making it this far and remember, there are only a few more days until the weekend arrives. So keep plugging away — it will make the time go faster. Meanwhile, we invite you to join us for a delightful cup of stimulation. Our choice today is glazed doughnut. No prescription is required. Meanwhile, here is the latest menu of tidbits to help you on your way. Have a wonderful day, and please do stay in touch. …

A Moderna (MRNA) Covid-19 vaccine led patients to produce antibodies that can neutralize the novel coronavirus that causes the disease, though it caused minor side effects in many patients, according to the first published data from an early-stage trial, STAT writes. However, many experts said the results were not sufficient to draw many conclusions. The data roughly mirror the results from a similar vaccine being produced by Pfizer (PFE) and BioNTech (BNTX), which were released July 1.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!